aminopterin has been researched along with Pleural Effusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilreath, JA; Halwani, AS; McPherson, JP; Sedillo, C; Vrontikis, A | 1 |
| Hong, WK; Jeffries, D; Lee, JS; Libshitz, HI; Murphy, WK | 1 |
2 other study(ies) available for aminopterin and Pleural Effusion
| Article | Year |
|---|---|
Pralatrexate Monitoring Using a Commercially Available Methotrexate Assay to Avoid Potential Drug Interactions.
Topics: Aged; Aminopterin; Drug Interactions; Drug Monitoring; Folic Acid Antagonists; Furosemide; Humans; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Pleural Effusion; Reagent Kits, Diagnostic; Skin Neoplasms; Sodium Potassium Chloride Symporter Inhibitors; Treatment Outcome | 2016 |
Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIB or IV non-small cell lung cancer.
Topics: Adult; Aged; Aminopterin; Carcinoma, Non-Small-Cell Lung; Female; Folic Acid Antagonists; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pleural Effusion | 1990 |